Oncogenic SF3B1 mutations alter the splicing of mRNA noncoding regions to induce a novel therapeutic vulnerability. Sekrecki M, Sekrecka A, Lattupally RR, Le K, et al. Blood 2026;147:1941-1957.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sekrecki M, Sekrecka A, Lattupally RR, Le K, et al. Oncogenic SF3B1 mutations alter the splicing of mRNA noncoding regions to induce a novel therapeutic vulnerability. Blood 2026;147:1941-1957.
PMID: 41587094